Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort

Overview of attention for article published in BMC Cancer, October 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 6 tweeters

facebook: 2 Facebook pages

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 21 Mendeley

Summary Twitter Facebook Dimensions citations

So far, Altmetric has seen 8 tweets from 6 users, with an upper bound of 28,994 followers.

#PubSaludMurcia Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort https://t.co/5KbsvxbnjF

31 Jan 2019

Reply Retweet Favourite

New from #ERC_Research https://t.co/CmNTuhDZ3E Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort

08 Nov 2018

Reply Retweet Favourite

New from #CR_UK https://t.co/CmNTuhDZ3E Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort

08 Nov 2018

Reply Retweet Favourite

#PubSaludMurcia Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort https://t.co/es4SwKpyHX

25 Oct 2018

Reply Retweet Favourite

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 4 additional tweets.